Cargando…
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987023/ https://www.ncbi.nlm.nih.gov/pubmed/33758864 http://dx.doi.org/10.1101/2021.03.07.434227 |
_version_ | 1783668549993103360 |
---|---|
author | Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Lorenzi, Julio C C Flyak, Andrew I DeLaitsch, Andrew T Huey-Tubman, Kathryn E Hou, Shurong Schiffer, Celia A. Gaebler, Christian Wang, Zijun Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. |
author_facet | Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Lorenzi, Julio C C Flyak, Andrew I DeLaitsch, Andrew T Huey-Tubman, Kathryn E Hou, Shurong Schiffer, Celia A. Gaebler, Christian Wang, Zijun Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. |
author_sort | Muecksch, Frauke |
collection | PubMed |
description | Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. |
format | Online Article Text |
id | pubmed-7987023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-79870232021-03-24 Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Lorenzi, Julio C C Flyak, Andrew I DeLaitsch, Andrew T Huey-Tubman, Kathryn E Hou, Shurong Schiffer, Celia A. Gaebler, Christian Wang, Zijun Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. bioRxiv Article Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. Cold Spring Harbor Laboratory 2021-03-08 /pmc/articles/PMC7987023/ /pubmed/33758864 http://dx.doi.org/10.1101/2021.03.07.434227 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Lorenzi, Julio C C Flyak, Andrew I DeLaitsch, Andrew T Huey-Tubman, Kathryn E Hou, Shurong Schiffer, Celia A. Gaebler, Christian Wang, Zijun Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title | Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title_full | Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title_fullStr | Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title_full_unstemmed | Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title_short | Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies |
title_sort | development of potency, breadth and resilience to viral escape mutations in sars-cov-2 neutralizing antibodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987023/ https://www.ncbi.nlm.nih.gov/pubmed/33758864 http://dx.doi.org/10.1101/2021.03.07.434227 |
work_keys_str_mv | AT mueckschfrauke developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT weisblumyiska developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT barneschristophero developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT schmidtfabian developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT schaeferbabajewdennis developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT lorenzijuliocc developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT flyakandrewi developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT delaitschandrewt developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT hueytubmankathryne developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT houshurong developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT schifferceliaa developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT gaeblerchristian developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT wangzijun developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT dasilvajustin developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT postondaniel developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT finkinshlomo developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT choalice developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT cipollamelissa developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT oliveirathiagoy developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT millardkatrinag developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT ramosvictor developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT gazumyananna developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT rutkowskamagdalena developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT caskeymarina developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT nussenzweigmichelc developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT bjorkmanpamelaj developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT hatziioannoutheodora developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies AT bieniaszpauld developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies |